Crossmark

Targeted therapies for ER+/HER2- metastatic breast cancer

Crossref DOI link: https://doi.org/10.1186/s12916-015-0369-5

Published Online: 2015-06-09

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yamamoto-Ibusuki, Mutsuko

Arnedos, Monica

André, Fabrice
License Information

License valid from 2015-06-09
More Information

Article History

Received: 12 February 2015

Accepted: 14 May 2015

First Online: 9 June 2015